A multicenter, open-label extension study to assess the long-term safety, tolerability, and efficacy of bimekizumab in the treatment of subjects with active psoriatic arthritis

  • Antony, Anna (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date12/10/21 → 11/10/26

Keywords

  • multicentre trial
  • treatment safety
  • treatment efficacy
  • psoriatic arthritis